GCT organizes Investigators’ Meeting for medical device study in Romania
GCT started the new year with conducting an Investigators’ Meeting on behalf of the European Sponsor – NanoGun Technology (NGT). NGT is an innovative company certified by the French government in nanomaterial biotechnology. IMDENDRIM is an experimental in situ anticancer treatment of solid tumors nonresponsive to conventional therapy.
January 11, 2021
Study in Primary Mitochondrial Myopathy (PMM) Awarded
GCT has been selected to run a new project in patients diagnosed with PMM by its long-term Client. This Phase 2, multicenter, double-blind, placebo-controlled study will be managed by GCT team in Czech Republic and Hungary.
January 11, 2021
GCT Ukraine is moving to a larger facility
Global Clinical Trials first established its operations and a physical office in Ukraine in 2006. Among other projects, we are presently in the active start-up phase and opening 25 sites for a large global study in non-small lung cancer patients.
It is our pleasure to announce that we are moving to a new location to create an appropriate environment for our growing operations and headcount in the country.
January 7, 2021
The Holiday Season across the globe. It’s time to take the stock of our achievements!
As the winter holidays are celebrated all over the World and the New Year is just around the corner, our global team wants to take a moment to say thank you for your support and partnership.
Have a look at where 2020 took us!
December 24, 2020
New Scientific Project in Russia
GCT has been awarded a new multinational scientific project in patients diagnosed with Schizophrenia and other related psychiatric disorders.
GCT will manage the whole scope of services for the project including the local biosamples logistics and regulatory support.
December 10, 2020
Why CNS Clinical Trials are More Successful in Eastern Europe
With more than 19 years of experience in conducting CNS trials, we are now seeing that studies in Eastern Europe are becoming more and more popular among sponsors worldwide.
Here are the reasons why... (continue reading)
December 9, 2020
GCT to Perform Booster Visits in Russia
The Sponsor is running an international phase III trial in Crohn’s disease. Study recruitment is challenged by initial low incidence of the disease, combined with a big number of competing trials, as well as COVID-19 impact. As an escalation strategy and to reengage sites that are behind on the enrollment, the Sponsor decided to perform booster visits, including on-site visits by GCT team in Russia.
November 30, 2020
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.